Phospholamban anticorps (N-Term)
Aperçu rapide pour Phospholamban anticorps (N-Term) (ABIN2743681)
Antigène
Voir toutes Phospholamban (PLN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Recognizes endogenous levels of Phospholamban (pS16/T17) protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
KLH-conjugated synthetic peptide encompassing a sequence within the N-terminal region of human Phospholamban (pS16/T17).
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ICC (1:100 - 1:500), IF, WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- Phospholamban (PLN)
-
Autre désignation
- PLN / Phospholamban
-
Sujet
-
Name/Gene ID: PLN
Synonyms: PLN, CMD1P, CMH18, PLB, Cardiac phospholamban, Phospholamban -
ID gène
- 5350
-
Pathways
- Negative Regulation of Transporter Activity
Antigène
-